يعرض 1,081 - 1,100 نتائج من 1,800 نتيجة بحث عن '(( 13 1 decrease ) OR ( 10 (((meter OR peter) decrease) OR (((nn decrease) OR (a decrease)))) ))*', وقت الاستعلام: 0.18s تنقيح النتائج
  1. 1081

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) حسب Mohammed Ibn-Mas'ud, Danjuma

    منشور في 2023
    "…Conversely, patients with non-heart failure-related polypharmacy had increased risks of ICU admissions (aOR=1.78, 95% CI: 1.13 – 2.70). ConclusionIn an examination of a database of patients with chronic heart failure, major non-heart failure-related polypharmacy was associated with increased risks in intensive care admissions. …"
    احصل على النص الكامل
    احصل على النص الكامل
    احصل على النص الكامل
  2. 1082
  3. 1083
  4. 1084
  5. 1085
  6. 1086
  7. 1087
  8. 1088
  9. 1089
  10. 1090
  11. 1091
  12. 1092
  13. 1093
  14. 1094
  15. 1095
  16. 1096
  17. 1097

    Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey حسب Turner, Stuart J.

    منشور في 2013
    "…Univariate sensitivity analysis highlighted that increasing the duration of voriconazole by >1.2 days or decreasing LAmB by >1.0 days changes the result. Monte Carlo Simulation resulted in 69.4% of simulations favouring voriconazole per patient treated.Conclusion: There is a strong likelihood that voriconazole is economically more favourable than LAmB in the empiric treatment of IFI in Turkey.…"
    احصل على النص الكامل
    احصل على النص الكامل
  18. 1098
  19. 1099
  20. 1100